You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 231 No. 13, March 31, 1975 TABLE OF CONTENTS
  JAMA
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (62)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Imipramine-Induced Heart Block A Longitudinal Case Study

Shepard J. Kantor, MD; J. Thomas Bigger, Jr., MD; Alexander H. Glassman, MD; Daniel L. Macken, MD; James M. Perel, PhD

JAMA. 1975;231(13):1364-1366.


Abstract

A 2:1 atrioventricular block developed during treatment with the tricyclic antidepressant imipramine in a 74-year-old man with a three-year history of right bundle-branch block. Serial cardiographic studies and determinations of blood imipramine concentrations showed that the heart block was directly related to the plasma concentration of the drug and occurred below the atrioventricular node in the His-Purkinje system.

(JAMA 231:1364-1366, 1975)



Author Affiliations

From the departments of medicine (Drs. Bigger and Macken), pharmacology (Dr. Perel) and psychiatry (Drs. Glassman and Kantor), College of Physicians and Surgeons, Columbia University, and the New York State Psychiatric Institute (Drs. Glassman, Kantor, and Perel), New York.


Footnotes

Reprint requests to the New York State Psychiatric Institute, 722 W 168th St, New York, NY 10032 (Dr. Kantor).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Tricyclic Antidepressants in the Intensive Care Unit
Dec and Stern
J Intensive Care Med 1990;5:69-81.
ABSTRACT  

Tricyclic Antidepressants in Depressed Patients With Cardiac Conduction Disease
Roose et al.
Arch Gen Psychiatry 1987;44:273-275.
ABSTRACT  

Nortriptyline in Depressed Patients With Left Ventricular Impairment
Roose et al.
JAMA 1986;256:3253-3257.
ABSTRACT  

Cardiovascular Effects of Polycyclic Antidepressants
Mahapatra et al.
ANGIOLOGY 1986;37:709-717.
ABSTRACT  

The Use of Imipramine in Depressed Patients With Congestive Heart Failure
Glassman et al.
JAMA 1983;250:1997-2001.
ABSTRACT  

Major Adverse Reactions During Desipramine Treatment: Relationship to Plasma Drug Concentrations, Concomitant Antipsychotic Treatment, and Patient Characteristics
Nelson et al.
Arch Gen Psychiatry 1982;39:1055-1061.
ABSTRACT  

Cardiovascular Effects of Therapeutic Doses of Tricyclic Antidepressants: A Review
Glassman and Bigger
Arch Gen Psychiatry 1981;38:815-820.
ABSTRACT  

Is Physostigmine Effective for Cardiac Toxicity of Tricyclic Antidepressant Drugs?
Bigger et al.
JAMA 1977;237:1311-1311.
ABSTRACT  

Tricyclic Antidepressant Cardiotoxicity
Robinson and Barker
JAMA 1976;236:2089-2090.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1975 American Medical Association. All Rights Reserved.